Helicore Biopharma is at the forefront of developing cutting-edge treatments for obesity and related disorders. | | | 5 - 10 | 2025 | $65,000,000 |
Remedy brings the doctor to you, via 24/7 video visits, house calls and low-wait walk-in clinics. Get better, faster. | | | 1 - 10 | 2025 | $500,000 |
Vocality delivers enterprise-grade AI translation and interpretation tools purpose-built for healthcare. Our platform integrates natively with hospital systems, providing real-time, secure language solutions that reduce costs, expand access to care, and improve patient outcomes. With fine-grained control, enterprise-level security, and seamless workflow integration, Vocality ensures that every patient voice is heard clearly, securely, and instantly. | | | 2 - 10 | 2025 | $500,000 |
Nexa builds implantable microchips for cattle monitoring and health management. | | | 2 - 10 | 2025 | $500,000 |
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven history of progressing cell-depleting treatments through clinical trials, and a strong pipeline. | San Francisco | CA | 20 - 50 | 2025 | $120,000,000 |
Nome is the Operating System for Personalized Therapies™. Where traditional pharmaceutical infrastructure was built for mass-market drugs, Nome provides the coordination layer that rare disease programs require: AI-driven genomic assessment, regulatory navigation, researcher and manufacturer matching, and end-to-end program management — all in one platform. Nome serves as a tech-enabled service company sitting between the patient and the clinic. For a patient or family, Nome delivers a free therapy eligibility assessment in 1–2 weeks, followed by an execution-ready action plan. For clinicians and foundations, Nome functions as an intelligent scientific program manager — handling the orchestration complexity that has historically made personalized drug development inaccessible outside of elite academic medical centers. The platform is modality-agnostic, with current focus on antisense oligonucleotides and gene therapies. Nome also operates as a preclinical CRO, offering target design, toxicology studies, and pre-clinical manufacturing services for rare genetic diseases. Founded by Steven Ringel — a rare disease patient, former Sema4, GeneDx, and Tempus operator, and founder of the Kizuna Foundation (foundation to develop retinal gene therapies) — Nome emerged from stealth in October 2025 backed by Twelve Below, Refactor Capital, and Inflect Health. | | | 1 - 10 | 2025 | $2,700,000 |
Claim Health is the automation layer for your revenue operations. From referral to reimbursement, their AI removes the administrative burden — so your team can focus on care. Claim Health prevents it. They catch denials before they happen, automate the work drowning ops teams, and connect every step from referral to cash so agencies can scale without adding headcount. | | | 2 - 10 | 2025 | $4,900,000 |
We help infusion clinics get every biologic approved and paid for. Biologics are expensive specialty medications that cost $80K/year and are very hard to access. Each insurer has different coverage rules and requirements that change constantly.
Today, clinics navigate through dozens of portals and spreadsheets and manually fill out countless forms to get their patients access to biologics.
Ruma solves these problems. First, Ruma maps each drug to each payer's formulary rules and required forms. We then automate the form-filling for prior authorizations. Lastly, we enroll patients in copay assistance programs, all in a singular workflow and platform. | | | 2 - 10 | 2025 | $2,000,000 |
MindPortal makes a wearable device that can read your mind. It’s as accurate as Neuralink but requires no surgery. | | | 5 - 10 | 2025 | $5,000,000 |
Tenvie Therapeutics is a biotechnology company founded to improve patients' lives with neurological, cardiometabolic, and ophthalmic diseases. The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lysosomal issues, with a robust pipeline inherited from Denali Therapeutics. Tenvie is progressing a range of therapeutics aimed at addressing neurological, cardiometabolic, and ophthalmic conditions. Its collection of fully owned, highly brain-penetrant, and precisely designed peripherally restricted small molecules targets three main factors of disease: alleviating inflammation, correcting metabolic dysfunction, and rejuvenating lysosomal function. | San Francisco | CA | 20 - 50 | 2025 | $200,000,000 |
Callio Therapeutics focuses on developing next-generation, multi-payload antibody-drug conjugates to maximize therapeutic benefits. | | | 5 - 20 | 2025 | $187,000,000 |
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout. | | | 10 - 50 | 2025 | $205,000,000 |
At Amby Health, we’re revolutionizing emergency medical services (EMS) by automating quality reviews and billing processes. Our AI-powered platform ensures that every patient care report (PCR) is reviewed in real time, eliminating manual errors and compliance risks, accelerating reimbursements, and ultimately enhancing patient care. | | | 2 - 10 | 2025 | $500,000 |
Play Health delivers data and AI-driven care software that enables health systems and value-based care organizations to improve outcomes, reduce unnecessary utilization, and close the massive data gap that has left over 30 million women in the US under- or inappropriately treated during midlife transitions.
Play Health's platform enables patients to track symptoms, cycles, medications, lifestyle factors, and biometrics while giving clinicians longitudinal data and AI-driven analytics to manage midlife transitions more effectively. We close the data gap with comprehensive tracking, improve quality metrics for value-based care organizations, and reduce unnecessary utilization through earlier intervention and more targeted treatment-all while generating the real-world evidence needed to transform how perimenopause and menopause are treated in our healthcare system.
Perimenopause is our starting point, not our end goal. We're developing precision medicine infrastructure for midlife and longevity-creating the data foundation and analytical capabilities needed to deliver personalized care at scale for the life transitions that determine healthspan. By partnering with forward-thinking health systems today, we're building the evidence and infrastructure to make precision longevity medicine accessible to everyone tomorrow. | | | 2 - 10 | 2025 | |
Trapeze is an healthcare application that allows doctors to answer patient calls 24/7. | | | 10 - 50 | 2025 | $500,000 |
We connect you with a care advocate who takes care of the paperwork, phone calls, and everything in between - so you can focus on healing. Covered by Medicare. | | | 10 - 50 | 2025 | $8,400,000 |
Mos Health creates a digital health platform that blends an AI-powered application with its own line of supplements. | | | 1 - 10 | 2025 | $1,100,000 |
Noded Ai is preparing yourself for that customer meeting is tough. Noded brings them all together using your notes history and gives you exactly what you needed , when you need it. So you’re always prepared and one step ahead. | New York | NY | 10 - 50 | 2024 | $48,000,000 |
Nura Health is a molecular diagnostics company whose mission is to advance women's health through the development and delivery of novel practice-changing non-invasive tests. We prioritize innovative, evidence-based diagnostic methods enhanced by AI & Machine Learning in order to improve clinical outcomes for complex and debilitating diseases such as endometriosis, infertility disorders, and genetic conditions that impact quality of life and longevity. | | | 1 - 10 | 2024 | |
Fluency is an AI-powered physician companion that enables medical practices to begin patient symptom collection prior to the appointment. Patient information is used to generate patient reports and information is extracted to complete clinical documentation in electronic health record systems. Doctors save time on patient information collection, examination, and documentation, allowing them to see more patients. | | | 1 - 10 | 2024 | |
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area. | San Francisco | CA | 50 - 200 | 2024 | $1,000,000,000 |
Arini is an AI receptionist for dental practices that answers phone calls, and schedules appointments. | San Francisco | CA | 1 - 10 | 2024 | $500,000 |
K-Scale Labs is a robotic engineering company specializing in creating open-source humanoid robots. | New York | NY | 2 - 10 | 2024 | $500,000 |
Offcall is tackling for physician burnout by providing salary and work transparency, along with financial education. | San Francisco | CA | 5 - 20 | 2024 | $2,000,000 |
Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. The Company is advancing a pipeline of therapeutic candidates addressing areas of high unmet need including wet age-related macular degeneration (AMD). Eyconis is partnered with a syndicate of leading biopharma investors including Frazier Life Sciences, RA Capital Management, venBio Partners, and HealthQuest Capital. The Company is headquartered in Redwood City, California, including research & development laboratories with scientific and manufacturing team members. | | | 10 - 50 | 2024 | $85,251,248 |
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients with neurodegenerative illnesses. | South San Francisco | CA | 10 - 50 | 2024 | $101,000,000 |
Sonologi, Inc. is a deep-tech startup based in Palo Alto, specializing in wearable ultrasound technology for continuous real-time imaging in critical care and remote monitoring. Our patches enable non-invasive, high-resolution imaging of multiple organs simultaneously, providing comprehensive patient data for better decision-making. Sonologi focus on applications in ICU, OR, emergency care, and remote monitoring, integrating AI for advanced image analysis and diagnostics. | Palo Alto | CA | 2 - 10 | 2024 | $2,500,000 |
City Therapeutics is a biopharmaceutical company focusing on engineering next-generation small-interfering RNAs (siRNAs) to enhance RNAi-based therapies. The company develops a pipeline of innovative RNAi therapeutics aimed at addressing various disease indications. City Therapeutics prioritizes improving and expanding RNAi technology to achieve better patient outcomes. The leadership team includes experienced scientists and industry professionals dedicated to advancing the field of RNA interference. | Cambridge | MA | 10 - 50 | 2024 | $234,500,000 |
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases. | Waltham | MA | 50 - 200 | 2024 | $1,000,000,000 |
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on promising targets, and implementing them in disease areas with considerable unmet needs. | San Diego | CA | 10 - 50 | 2024 | $180,000,000 |
Jupiter Endovascular is a medical technology start-up. Its mission is to cover the entire spectrum of cardiovascular illness, seeing compelling potential to reinvent treatments for millions of people. | Menlo Park | CA | 10 - 50 | 2024 | $21,000,000 |
Kabilah streamlines shift change for nurses with an AI-powered assistant that replaces paper reports. | Stanford | CA | 1 - 10 | 2024 | $500,000 |
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies. | | | 10 - 50 | 2024 | $105,000,000 |
Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation. That aims to focus on pausing and restarting biological functions through freezing to prevent tissue damage in dead bodies. | San Francisco | CA | 20 - 50 | 2024 | $48,000,000 |
Coeptis Therapeutics focuses on the development and acquisition of pharmaceutical products. Coeptis’ pipeline is evolving from the partnerships being created with multiple pharmaceutical companies currently. As these relationships unfold, the product pipeline will be updated accordingly. | Wexford | PA | 5 | 2024 | $25,192,500 |
GEMMABio is a therapeutics company that supports the rare disease community. | Philadelphia | PA | 50 - 100 | 2024 | $34,000,000 |
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages. | Wilmington | DE | 20 - 50 | 2024 | $5,500,000 |
Advancing healthcare through adaptable and innovative inventory management solutions. | Haddonfield | NJ | 1 - 10 | 2024 | $1,250,000 |
nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques. | Boston | MA | 50 - 100 | 2024 | $75,000,000 |
C3 is a defense technology company developing novel solutions for medics. Built by Silent Ventures. | Ann Arbor | MI | 10 - 500 | 2024 | $55,000,000 |
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi. | Boston | MA | 10 - 50 | 2024 | $100,000,000 |
Our HIPAA-Compliant AI Assistant will save you hours of paperwork time a week. Summarize parent interviews, caregiver trainings, and RBT supervision. Automate insight extraction from client records. Generate huge parts of treatment plans.
Interested in trying it out? No credit card required. No client data needed. Sign up for free! | | | 1 - 10 | 2024 | |
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases. The company advances EXPD-101, an oral once-daily inhibitor of DPP1, which targets neutrophilic inflammation and is positioned for chronic obstructive pulmonary disease (COPD) and other neutrophil-driven indications. It pursues global clinical development of EXPD-101 while exploring expansion into bronchiectasis, neutrophilic asthma, and related conditions. The leadership team combines expertise in drug discovery, translational science, clinical development, and business strategy. Expedition Therapeutics operates a model that integrates in-licensing of external innovation with internally generated programs. | | | 2 - 10 | 2024 | $165,000,000 |
At Neural Science Institute, we are revolutionizing people's independence to live extraordinary lives. We harness the remarkable power of neuroplasticity to explore new frontiers and address behavioral health issues. Our innovative neural feedback therapy renews brain neuroplasticity and empowers individuals to embark on transformative journeys toward restoring vibrant health and well-being. Our primary mission is to revolutionize recovery by breaking the addiction cycle through combining neurotherapy with existing treatment methods to allow people to live a life free of substance disorders. | | | 10 - 50 | 2024 | $100,000 |
Developing innovative therapeutics to materially improve the lives of patients. We strive to be transparent and open in our goals, plans, and progress. | San Diego | CA | 20 - 50 | 2024 | $370,000,000 |
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases. | San Diego | CA | 20 - 50 | 2024 | $480,000,000 |
Endo Health creates a gamified ''AI endocrinologist'' for type 2 diabetes management. They are creating a pleasant AI medical assistant that will walk patients through every stage of diabetic control, complete with gamified involvement. | San Francisco | CA | 1 - 10 | 2024 | $1,000,000 |
PilloVR is a pioneering healthtech startup dedicated to transforming pediatric healthcare through virtual reality. Our mission is to make medical visits less stressful and more engaging for young patients by using immersive VR experiences as a distraction tool during procedures such as vaccinations and blood draws. With content designed specifically for children, PilloVR helps reduce anxiety and enhance the overall patient experience while also benefiting healthcare professionals by streamlining routine procedures. Currently being tested in over 50 clinics across the U.S., including renowned institutions like Harvard, Yale, and UC Irvine, PilloVR is setting a new standard for compassionate, innovative pediatric care. | | | 1 - 10 | 2024 | $3,000,000 |
KALM Therapeutics provides non-steroidical treatment for eczema and psoriasis. | Huntsville | AL | 2 - 10 | 2024 | $590,380 |
Praia Health is a cutting-edge consumer platform for health systems that transforms the delivery of personalised health solutions on a large scale, allowing digital transformation. | Chicago | IL | 20 - 50 | 2024 | $20,000,000 |
careCycle is an AI workforce for Medicare agencies and FMOs, supporting top agencies in their operations. | | | 5 - 10 | 2024 | $2,000,000 |
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases. | Knoxville | TN | 2 - 10 | 2024 | $3,000,000 |
Kairo Health builds AI agents that help deliver patient care at a fraction of the cost. | | | 2 - 10 | 2024 | $500,000 |
Rx Save Card is an innovative pharmacy benefit solution that allows businesses and employees to integrate an assortment of cost-cutting initiatives into one integrated navigation and payment experience. | Chicago | IL | 1 - 10 | 2024 | $1,700,000 |
Responsive Arthroscopy is a medtech company that offers medical devices for the sports medicine field. | | | 10 - 50 | 2024 | $9,999,999 |
Oma Care is to empower, assist, and compensate people who care for our most vulnerable citizens—family caregivers. | San Francisco | CA | 2 - 10 | 2024 | $500,000 |
Lift Labs is a creator of a suite of home health hardware for people living with Parkinson's Disease and Essential Tremor. Its core R&D focuses on areas of healthcare, sustainability, safety, and education. The company was founded in 2010 and is headquartered in San Francisco, California. | San Francisco | CA | 5 - 10 | 2024 | $2,900,000 |
At Horus Health, we're building agentic workflows to streamline and accelerate healthcare billing compliance, allowing health systems to autonomously review 100% of patient records, surface millions in missed revenue, and ensure compliance.
We work with some of the largest health systems in the United States. | | | 5 - 10 | 2024 | |
Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free for commercial applications. By enabling accurate predictions without the need for multiple sequence alignments, Chai-1 advances the capabilities of molecular modeling in the life sciences. | San Francisco | CA | 5 - 20 | 2024 | $231,000,000 |
DeltaGen is an enterprise AI company transforming buyside M&A by automating 80% of manual workflows—eliminating inefficiencies and accelerating deal velocity for corporate development teams, private equity firms, and strategic acquirers. Unlike traditional AI tools that rely on manual prompting, DeltaGen’s no-prompt AI delivers highly accurate, deterministic insights with seamless integration. | | | 50 - 268 | 2024 | $2,700,000 |
Z-Score Health is a forward-thinking healthcare company leveraging technology to offer personalized preventive care. Their approach integrates comprehensive health risk assessments using a sophisticated SaaS platform and mobile applications, focusing on areas like women's health, geriatric care, and sexual health. They emphasize patient satisfaction and convenience, aiming to make healthcare more accessible and effective through technology. This summary provides an essence of their services and mission; for a detailed description, you would need to refer to their official website or professional profile. | Atlanta | GA | 1 - 10 | 2024 | $600,000 |
World Class Health is a Hospitals and Health Care company. | New York | NY | 1 - 10 | 2024 | |
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines. | | | 10 - 50 | 2024 | $93,500,000 |
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | Boulder | CO | 20 - 50 | 2024 | $41,000,000 |
Thrive AI Health builds an AI health coach. Thrive AI Health use generative AI to hyper-personalize and scale behavior change. | | | 10 - 50 | 2024 | $8,049,999 |
Zarminali Health is a medical organization. | Chicago | IL | 20 - 50 | 2024 | $150,000,000 |
Astrix builds AI purchasing agents for healthcare providers. Astrix helps providers secure better deals on recurring medical supplies, equipment, and pharmacy orders by using AI to find the best offers from reputable vendors. Powered by generative AI, Astrix aggregates and normalizes data from millions of sources, delivering actionable pricing insights for buyers and sellers alike. Our team brings expertise in building AI systems from Palantir, Oxford, Duke Health, and MedStar Health. Backed by Y Combinator, Astrix operates globally from San Francisco, NYC, and London. | | | 2 - 10 | 2024 | $2,000,000 |
GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation. | | | 20 - 100 | 2024 | $300,000,000 |
Trovo Health uses AI technology to provide comprehensive healthcare solutions, combining smart algorithms with professional human coaching to deliver personalized patient care. | New York | NY | 10 - 50 | 2024 | $60,000,000 |
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications. | Waltham | MA | 4 | 2024 | $797,600,000 |
Mosaic health data provides medical records of complete data of a patient's health across the continuum of care | | | 2 - 10 | 2024 | $500,000 |
With a mission to keep athletes active and thriving in their chosen sports for as long as possible, Eternal provides members with a holistic understanding of their health, fitness, and benchmarks for key markers of the aging process along with guidance from high-performance care teams to support every stage of an athlete’s journey. | | | 10 - 50 | 2024 | $13,300,000 |
ClinicOS helps single provider plastic surgery clinics generate more leads by providing great visualizations.
Our mission is to generate 1 million new leads for plastic surgery clinics. | | | 10 - 50 | 2024 | |
Oath Surgical is creating the surgical care of the future, one that is value-based by design, tech-powered, and led by surgeons. The first vertically integrated system that combines tech-first surgical centers with AI software. | | | 20 - 50 | 2024 | $34,000,000 |
Seaport Therapeutics operates as a clinical stage biopharmaceutical company. | Boston | MA | 20 - 100 | 2024 | $340,000,000 |
Ply Health’s platform delivers a better and faster contracting and credentialing experience. Using our tech + automation and behavioral health expertise, we've been able to get providers in network with payers weeks to months faster than other vendors.
Ply Health partners with physical practices, digital practices, build-your-own-business platforms and new provider entrepreneurs in behavioral to magically simplify data collection, enrollment submission, follow ups and record keeping.
Ply Health is backed by YCombinator and is based in San Francisco. | San Francisco | CA | 5 - 10 | 2024 | $500,000 |
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets. | San Francisco | CA | 5 - 20 | 2024 | $92,000,000 |
Ausa Health offers a device that collects health data like blood pressure, heart rate, and blood sugar. Users can track ear, nose, throat, and body temperature with the device. The system lets people store all their health records in one app. Virtual doctor consultations are possible through the platform. The service helps users and doctors check health status anytime and anywhere. | | | 2 - 10 | 2024 | $932,500 |
Navigator Medicines operate as a biotech company that leads the advancement of biologics for targeted immune regulation & restoration. | Scotch Plains | NJ | 5 - 20 | 2024 | $100,000,000 |
AT4K specializes in and alone performs in-person autism evaluations. It is committed to reducing the time it takes for children to be evaluated for Autism Spectrum Disorder (ASD) and providing comprehensive and reliable evaluations that enable early intervention and individualized care. | Grapevine | TX | 10 - 50 | 2024 | $2,500,000 |
LatentSpace Therapeutics has developed a first-of-its-kind approach to small molecule design. Our platform integrates predictive efficacy and safety fromm the onset of the design process; we create best-in-class cancer therapies with large therapeutic windows to serve high volume complex cancer needs. | | | 2 - 10 | 2024 | |
At Mindwavez AI, we envision a world where faith and mental health are pillars of strength for everyone. Our mission is to empower faith-driven professionals with seamless mental health support, uniting purpose and passion to revolutionize the future of work and well-being. Our inclusive, AI-powered well-being solution is designed for small and medium teams, offering a cost-friendly platform to prioritize faith and mental health. With our app, you'll revolutionize workplace dialogue around faith and mental health, fostering an atmosphere of good health, resilience, strong faith, and engagement. Instead of merely offering a typical content library, we are passionately dedicated to developing tools that are accessible, faith-driven, and truly transformative. Mindwavez AI empowers you to proactively support your team's holistic well-being, ensuring every member thrives. | | | 1 - 10 | 2024 | |
The Catch Mobile Health team brings together accomplished business and medical professionals from across the country with the shared vision to improve access to specialist care in rural and underserved communities. | | | 5 - 20 | 2023 | $2,275,000 |
Flint is a global healthcare talent recruiting platform. Flint supports healthcare staffing needs. Flint sources nurses from around the globe, enabling clients to let the organization manage the entire recruiting, licensing, immigration, and relocation processes. | San Francisco | CA | 20 - 50 | 2023 | |
We are Montara Therapeutics, a San Francisco-based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB).
We bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and domain expertise in mitophagy.
Our mission is to create innovative therapies for diseases of the CNS, with a focus on precision medicine and genetically validated targets to enhance drug safety and efficacy. | San Francisco | CA | 20 - 50 | 2023 | $31,300,000 |
Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials. Sealonix is working on a sealant patch that will provide quick hemostasis for abdominopelvic and orthopedic operations. The PramStat patch is intended to bioabsorb within one week of implantation. | Bedford | MA | 2 - 10 | 2023 | $20,000,000 |
Caire is a developer of a virtual-first care platform that puts the patient at the center. | New York | NY | 10 - 50 | 2023 | $23,100,000 |
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness. | Laguna Hills | CA | 10 - 50 | 2023 | $10,000,000 |
Savoy Life is a virtual care solution that connects long-term care operators and residents with high-quality, coordinated healthcare services. | Virginia | NE | 2 - 10 | 2023 | $3,000,000 |
Amplifyer Bio is a biotechnology research company that develops technology of transformative potential for the liquid biopsy field. | Lexington | MA | 5 - 10 | 2023 | $7,078,494 |
In-House Health is an AI-powered technical platform for modern nursing teams. | Denver | CO | 10 - 50 | 2023 | $4,000,000 |
REMspace is a neurotechnology company that offers science-backed devices that help to improve sleep quality. | Redwood City | CA | 10 - 50 | 2023 | $1,000,000 |
Atraverse Medical offers a product development for left-heart access technology to simplify workflows and improve patient outcomes. | Chicago | IL | 20 - 50 | 2023 | $41,900,000 |
Being Health is a psychiatrist-led mental health practice that leverages the best of psychiatry. | New York | NY | 10 - 50 | 2023 | $5,400,000 |
Bio Usawa is a biotechnology company that develops monoclonal antibodies for cancer, ophthalmic, and infectious diseases. | | | 1 - 10 | 2023 | $2,608,900 |
Shasta Health is a physical therapy center that offers patient acquisition, billing, care plans, and other care facilities. | San Francisco | CA | 2 - 10 | 2023 | $500,000 |
Foundation Health is a telehealth and nationwide pharmacies and diagnostic distribution centre | San Francisco | CA | 10 - 500 | 2023 | |
ROSE Diagnostics' objective is to improve cancer diagnostics by moving the pathology lab to the cancer biopsy clinic and offering a suite of simple point-of-care diagnostic devices. | Carlsbad | CA | 1 - 10 | 2023 | $1,005,000 |
EvolutionaryScale is a developer of biological artificial intelligence models for therapeutic design. The business predicts protein structures by combining biological data from DNA sequences, gene expression, and epigenetic states, allowing scientists to use massive language models to create RNA-based medicinal therapies. | New York | NY | 20 - 50 | 2023 | $142,000,000 |
Avenacy is a rapidly growing U.S.-based specialty pharmaceutical company focused on providing critical injectable medications used to treat patients in various medically supervised settings, from acute care hospitals to outpatient clinics and physician offices. Through a rigorous and optimized selection process, the Company is building out a pipeline of high-quality FDA approved injectable products to ensure a resilient portfolio that can meet the needs of today’s dynamic drug supply chain. With an experienced team, commitment to quality and reliability, and product offerings intended to facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential injectable medications. | Schaumburg | IL | 10 - 50 | 2023 | $26,030,368 |